This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Leads Biolabs Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Huan Lin: Innovator in Antibody Technology
Introduction
Huan Lin is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. His work focuses on innovative solutions for treatment and diagnosis, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Huan Lin holds 1 patent for his invention titled "Antibodies binding TNFR2 and uses thereof." This patent describes a novel antibody and antibody fragment that specifically binds to TNFR2. The invention also includes a composition comprising the antibody or antibody fragment, as well as a nucleic acid encoding the antibody or its fragment. Furthermore, it outlines the use of these antibodies and fragments for treatment and diagnosis, highlighting their potential in therapeutic applications.
Career Highlights
Huan Lin is associated with Nanjing Leads Biolabs Co., Ltd., where he continues to work on groundbreaking research in antibody technology. His career is marked by a commitment to innovation and a focus on developing solutions that can significantly impact healthcare.
Collaborations
Huan Lin collaborates with notable colleagues, including Xiaoqiang Kang and Shoupeng Lai. Their combined expertise fosters a productive research environment, driving advancements in their field.
Conclusion
Huan Lin's contributions to antibody technology exemplify the spirit of innovation in biotechnology. His work not only enhances our understanding of TNFR2 but also paves the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile